Clover Health Investments Corp (CLOV)’s financial ratios: A comprehensive overview

In the latest session, Clover Health Investments Corp (NASDAQ: CLOV) closed at $0.64 down -5.06% from its previous closing price of $0.67. On the day, 10650463 shares were traded.

Ratios:

For a deeper understanding of Clover Health Investments Corp’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Cowen on February 02, 2022, Upgraded its rating to Market Perform and sets its target price to $3 from $7 previously.

On February 02, 2022, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $6.

On January 19, 2022, SVB Leerink started tracking the stock assigning a Mkt Perform rating and target price of $3.SVB Leerink initiated its Mkt Perform rating on January 19, 2022, with a $3 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 14 ’24 when Loengard Anna U bought 137,000 shares for $0.73 per share. The transaction valued at 100,010 led to the insider holds 538,841 shares of the business.

Loengard Anna U bought 13,625 shares of CLOV for $9,946 on Mar 14 ’24. The Director now owns 15,125 shares after completing the transaction at $0.73 per share. On Sep 06 ’23, another insider, Loengard Anna U, who serves as the Director of the company, bought 11,000 shares for $1.30 each. As a result, the insider paid 14,300 and bolstered with 10,000 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 0.15 while its Price-to-Book (P/B) ratio in mrq is 1.07.

Stock Price History:

Over the past 52 weeks, CLOV has reached a high of $1.63, while it has fallen to a 52-week low of $0.66.

Shares Statistics:

A total of 393.27M shares are outstanding, with a floating share count of 375.65M. Insiders hold about 23.88% of the company’s shares, while institutions hold 19.65% stake in the company.

Earnings Estimates

There are BlackRock AAA CLO ETF different market analysts currently analyzing its stock. The consensus estimate for the next quarter is $0.64, with high estimates of $42.46 and low estimates of $14.76.

Most Popular

[the_ad id="945"]